TO DESIGNATE MAY 2026 AS SKIN CANCER AWARENESS MONTH.
Summary
House Resolution 1021 is a ceremonial resolution that designates May 2026 as Skin Cancer Awareness Month in Arkansas. The resolution recites public-health findings about the prevalence, preventability, and mortality of skin cancer and melanoma, and it emphasizes the importance of awareness, early detection, and sun-safety practices. It also highlights the role of Arkansas dermatology organizations and the University of Arkansas for Medical Sciences in education, research, and patient care.
The resolution encourages Arkansans to be more aware of the risks of skin cancer and the need for early diagnosis. It directs that copies of the adopted resolution be provided to the Arkansas Dermatological Society, the Arkansas Chapter of the Dermatology Trainee Advocacy Group, and UAMS’s College of Medicine and Department of Dermatology. As a resolution, it does not create or amend statutory law, but it serves as an official legislative recognition and public-awareness measure.
Impact
HR 1021 has no direct effect on Arkansas statutes, regulations, or appropriations. Its legal impact is limited to an official House designation of May 2026 as Skin Cancer Awareness Month and a formal encouragement of public education about skin cancer prevention and early detection. The practical effect is symbolic and promotional, aimed at public health awareness rather than changing the rights or obligations of any person or entity.
Sentiment
The available context suggests broad support and a positive, noncontroversial sentiment around the resolution. The bill was read and adopted, and there is no recorded committee debate or vote opposition in the provided materials. The resolution’s public-health focus, educational purpose, and recognition of medical organizations indicate it was treated as a consensus awareness measure.
Contention
No notable points of contention are reflected in the provided record. Because the measure is a commemorative resolution rather than substantive legislation, there is no evidence of disagreement over regulatory burdens, funding, or enforcement. The only identifiable emphasis is on encouraging sun-safety and early screening, which appears to have been uncontroversial among supporters and the adopting chamber.